Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus
- PMID: 7840596
- PMCID: PMC284772
- DOI: 10.1128/AAC.38.10.2495
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus
Abstract
For 212 oropharyngeal isolates of Candida albicans, the fluconazole MICs for 50 and 90% of strains tested were 0.5 and 16 micrograms/ml, respectively, and those of itraconazole were 0.05 and 0.2 micrograms/ml, respectively. Of 16 isolates for which fluconazole MICs were > 64 micrograms/ml, itraconazole MICs for 14 were < or = 0.8 micrograms/ml and for 2 were > 6.4 micrograms/ml. Most fluconazole-resistant strains remained susceptible to itraconazole; whether itraconazole will prove effective for refractory thrush remains to be shown.
Similar articles
-
In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.Antimicrob Agents Chemother. 1994 Jul;38(7):1530-3. doi: 10.1128/AAC.38.7.1530. Antimicrob Agents Chemother. 1994. PMID: 7979284 Free PMC article.
-
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002. J Clin Microbiol. 2002. PMID: 12202543 Free PMC article.
-
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.AIDS. 1997 Dec;11(15):1839-44. doi: 10.1097/00002030-199715000-00008. AIDS. 1997. PMID: 9412702
-
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.J Clin Microbiol. 1994 Sep;32(9):2092-8. doi: 10.1128/jcm.32.9.2092-2098.1994. J Clin Microbiol. 1994. PMID: 7814530 Free PMC article.
-
Antifungal drug resistance in pathogenic fungi.Med Mycol. 1998;36 Suppl 1:119-28. Med Mycol. 1998. PMID: 9988500 Review.
Cited by
-
In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs.Mycopathologia. 2001;149(2):63-8. doi: 10.1023/a:1007237711099. Mycopathologia. 2001. PMID: 11265163
-
Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.Eur J Clin Microbiol Infect Dis. 1997 Apr;16(4):314-8. doi: 10.1007/BF01695638. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9177967
-
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.Antimicrob Agents Chemother. 1996 Oct;40(10):2243-7. doi: 10.1128/AAC.40.10.2243. Antimicrob Agents Chemother. 1996. PMID: 8891122 Free PMC article.
-
Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays.J Clin Microbiol. 1995 Oct;33(10):2612-5. doi: 10.1128/jcm.33.10.2612-2615.1995. J Clin Microbiol. 1995. PMID: 8567892 Free PMC article.
-
Antifungal agents in the 1990s. Current status and future developments.Drugs. 1997 Apr;53(4):539-49. doi: 10.2165/00003495-199753040-00001. Drugs. 1997. PMID: 9098658 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical